1. Home
  2. EVO

as of 06-12-2026 4:00pm EST

$2.72
$0.00
0.00%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Founded: 1993 Country:
Germany
Germany
Employees: 4553 City: N/A
Market Cap: 994.5M IPO Year: N/A
Target Price: $7.00 AVG Volume (30 days): 28.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $2.31 - $4.42 Next Earning Date: 04-08-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 1.37% Revenue Growth (next year): 10.05%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered EVO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 67.05%
67.05%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: